ABH Healthcare IPO Day 3: Anil Baghi Hospital Operator’s ₹34.98 Crore SME Issue Moves Toward Final Bidding Day

ABH Healthcare IPO 2026 – Latest Update

ABH Healthcare Limited's IPO is currently open for subscription. The company is raising up to ₹34.98 crore through a completely fresh issue, with no Offer for Sale component.

The IPO opened on August 24, 2026 and is scheduled to close on August 27. The company has set a price band of ₹96 to ₹102 per equity share, with its shares proposed to list on the NSE SME platform on September 1.

ABH Healthcare IPO Details

The market lot is 1,200 shares, while the minimum retail application is two lots or 2,400 shares, requiring ₹2,44,800 at the upper price band.

What Does ABH Healthcare Do?

ABH Healthcare is a healthcare-services company operating under the Anil Baghi Hospital brand in Ferozepur, Punjab.

The company currently operates a 150-bed multi-specialty tertiary-care hospital offering healthcare services across approximately 25 specialties.

Its key clinical areas include cardiac sciences, neurology, gastroenterology, orthopaedics, joint replacement, minimally invasive brain and spine surgery, critical care and other medical specialties. The hospital also has supporting facilities including an in-house pharmacy and pathology laboratory.

The business model can broadly be understood as:

hospital infrastructure → doctors & medical specialists → inpatient/outpatient treatment → healthcare revenue.

Single Hospital Is Both an Opportunity and a Risk

One of the most important things to understand about ABH Healthcare is that its current operations are concentrated around one hospital in Ferozepur.

This gives the company an established regional healthcare base, but it also creates concentration risk. Current IPO analysis identifies the company's revenue as being entirely dependent on its single hospital operation.

A disruption involving this facility could therefore have a significant impact on the overall business.

For long-term growth, geographic expansion or the addition of new healthcare facilities could eventually become important.

FY2026 Revenue Crossed ₹52 Crore

ABH Healthcare has recorded steady recent growth.

Revenue increased to ₹52.59 crore in FY2026 from ₹49.32 crore in FY2025, while PAT improved to ₹5.64 crore from ₹5.35 crore.

The growth is moderate rather than exceptionally high, so post-IPO investors will likely focus on whether the hospital can increase patient volumes and revenue per occupied bed.

Profitability Has Improved Over the Longer Period

The longer-term profit trend is more notable.

ABH Healthcare's PAT increased from approximately ₹1.66 crore in FY2024 to ₹5.64 crore in FY2026.

That indicates a meaningful improvement in earnings as the hospital business matured.

The next challenge is sustaining this profitability while reducing leverage and funding future growth.

₹17 Crore Will Be Used for Debt Repayment

Debt reduction is the largest identified use of IPO proceeds.

ABH Healthcare intends to allocate approximately ₹17 crore toward repayment or prepayment of certain borrowings.

Use of IPO Proceeds

The ₹17 crore debt allocation represents nearly half of the overall IPO size.

The potential benefit is straightforward:

IPO capital → lower debt → lower interest burden → stronger cash flows → healthier balance sheet.

Debt Reduction Is Particularly Important

ABH Healthcare has historically operated with relatively high leverage.

Current IPO analysis indicates that the company's debt-to-equity ratio improved from approximately 5.69 in FY2024 to 3.20 in FY2026.

That is an improvement, but leverage remains an important factor.

The ₹17 crore IPO-funded debt repayment could therefore materially change the company's financial profile after listing.

Investors should watch the first post-IPO results for changes in:

borrowings + finance costs + debt/equity + operating cash flow.

₹5 Crore Will Strengthen Working Capital

Another ₹5 crore is earmarked for working-capital requirements.

Hospitals need continuous funding for everyday operations including medical consumables, pharmaceuticals, employees, maintenance and other clinical expenses.

Healthcare providers can also experience delays in receiving money from insurers and third-party administrators.

Fresh working capital can therefore help the hospital operate without relying as heavily on short-term borrowing.

Insurance Network Supports Patient Accessibility

Anil Baghi Hospital works with a network of more than 30 public and private insurance companies and TPAs.

This is important because insurance coverage can make higher-cost medical procedures more accessible to patients.

For the hospital, a wider insurer network can potentially support:

larger patient base + more cashless treatments + higher procedure volumes.

However, insurer-based revenue can also create receivable and collection-cycle considerations.

Specialty Care Can Improve Revenue per Patient

ABH Healthcare is not positioned only as a basic general hospital.

Its presence across areas such as cardiac sciences, neurology, gastroenterology, orthopaedics and complex surgical procedures gives it exposure to higher-value medical treatments.

Specialty care can potentially generate higher revenue per patient compared with routine consultations.

The business opportunity is therefore:

regional patient base + specialised doctors + advanced procedures → higher hospital utilisation and revenue potential.

Tier-3 Healthcare Creates an Interesting Opportunity

ABH Healthcare operates in Ferozepur rather than a major metro city.

This can be strategically important.

Patients in smaller cities have historically travelled to larger cities for specialised medical treatment. A well-equipped tertiary-care hospital closer to home can potentially capture some of that demand.

For patients, the value proposition can include:

specialised healthcare + shorter travel + local accessibility + insurance coverage.

For ABH Healthcare, building a strong regional healthcare brand could therefore create a defensible local position.

IPO Is 100% Fresh Issue

One positive structural feature is that there is no OFS.

The entire offering consists of 34,29,600 fresh shares.

This means existing shareholders are not selling their holdings through the IPO.

Instead:

IPO investors → fresh equity → ABH Healthcare → debt reduction + working capital + future business requirements.

IPO GMP Has Attracted Attention

ABH Healthcare entered the IPO with positive grey-market activity.

Ahead of the opening, grey-market quotations were reported in the range of approximately ₹27 to ₹30 per share.

At the ₹102 upper price, that represented notable unofficial listing expectations.

However, GMP can change rapidly throughout the subscription period and is neither exchange-regulated nor a guarantee of listing performance.

Investors should therefore give greater importance to business fundamentals, valuation and final subscription demand.

Key Strengths of ABH Healthcare

ABH Healthcare has established a multi-specialty tertiary-care hospital offering treatment across approximately 25 specialties from a 150-bed facility.

Its other positives include improving profitability, an established insurance/TPA network and the fact that the entire IPO is a fresh issue.

PAT has risen from around ₹1.66 crore in FY2024 to ₹5.64 crore in FY2026, showing a substantial improvement over two years.

The planned ₹17 crore debt repayment could also meaningfully strengthen the balance sheet.

Major Risks

The biggest risk is operational concentration.

ABH Healthcare currently depends on its single hospital in Ferozepur for its revenue, meaning geographic diversification is limited.

Other factors investors should monitor include healthcare regulation, availability of specialist doctors, patient occupancy, insurance receivables, medical-equipment costs and competition from hospitals in nearby regions.

Leverage is another important factor despite the improvement in the debt-to-equity ratio.

Finally, because ABH Healthcare will list on NSE SME, the stock may experience lower liquidity and greater volatility than typical mainboard shares.

What Investors Should Track After Listing

For ABH Healthcare, debt reduction and diversification beyond its existing Ferozepur hospital could become two of the most important long-term indicators.

Final View on ABH Healthcare IPO

ABH Healthcare's ₹34.98 crore NSE SME IPO is currently open, carrying a price band of ₹96–₹102 per share. The offering consists entirely of fresh shares, with no OFS.

The company operates the 150-bed Anil Baghi Hospital in Ferozepur, providing tertiary healthcare across approximately 25 specialties. FY2026 revenue stood at ₹52.59 crore while PAT reached ₹5.64 crore.

The use of IPO proceeds is particularly important: ₹17 crore is planned for debt repayment and ₹5 crore for working capital, with the balance available for inorganic growth and general corporate requirements.